Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

Lancet

Volumn 356, Issue 9224, 2000, Pages 113-121

  Sweat, Michael ^a   Gregorich, Steven ^b   Sangiwa, Gloria ^c   Furlonge, Colin ^d   Balmer, Donald ^e,f   Kamenga, Claudes ^g   Grinstead, Olga ^b   Coates, Thomas ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF DAR ES SALAAM   (Tanzania)

^d Queens Park Counseling Centre   (Trinidad and Tobago)

^e Kenya Assoc of Prof Counsellors   (Kenya)

^f UNIVERSITY OF CALGARY   (Canada)

^g FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COUNSELING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TANZANIA;

EID: 0034622353     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02447-8     Document Type: Article

References (32)

1. AIDS epidemic update: December 1999. 1999;UNAIDS, Geneva.
2. Epidemiological fact sheet on HIV/AIDS and sexually transmitted diseases: Kenya. 1998;UNAIDS, Geneva.
3. Epidemiological fact sheet on HIV/AIDS and sexually transmitted diseases: United Republic of Tanzania. 1998;UNAIDS, Geneva.
4. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet. 356:2000;103-112.
5. Mertens T.E., Low-Beer D. HIV and AIDS: where is the epidemic going? Bull World Health Organ. 74:1996;121-129.
6. Mugerwa R.D., Marum L.H., Serwadda D. Human immunodeficiency virus and AIDS in Uganda. East Afr Med J. 73:1996;20-26.
7. Marum E, Gumisiriza E, Moore M, Onen J. Impact of a social support club following HIV counseling and testing (CT), Uganda, 1993-1994. X International Conference on AIDS. Yokohama, August, 1994 (abstr 240C).
8. De Zoysa I., Phillips K.A., Kamenga M.C.et al. Role of HIV counseling and testing in changing risk behavior in developing countries. AIDS. 9(suppl A):1995;S95-S101.
9. Higgins DL, Galavotti C, Johnson R, O'Reilly KR , Rugg DL. The effect of HIV antibody counseling and testing on risk behaviors: are the studies consistent? VI International Conference on AIDS. San Francisco, July, 1990 (abstr ThD836).
10. Wolitski R.J., MacGowan R.J., Higgins D.L., Jorgensen C.M. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ Prev. 9(suppl):1997;52-67.
11. Allen S., Serufilira A., Bogaerts J.et al. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA. 268:1992;3338-3343.
12. Thomas J. Access to AIDS treatment in developing countries. a global issue of equity and human rights AIDS Analysis Asia. 4:1998;1-7.
13. Wilkinson D., Floyd K., Gilks C.F. Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa. an issue of cost-effectiveness and capacity AIDS. 12:1998;1571-1580.
14. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission: Thailand, 1996-1998. JAMA. 279:1998;1061-1062.
15. Guay L.A., Musoke P., Fleming T.et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomised trial Lancet. 354:1999;795-802.
16. Renault B., Birmingham K. Call to buy nevirapine for developing countries. Nat Med. 5:1999;1093.
17. Marseille E., Kahn J.G., Mmiro F.et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 354:1999;803-809.
18. Prescott N. Setting priorities for government involvement with antiretrovirals. Praag E., Fernyak S., Katz A. The implications of antiretroviral treatments: informal consultation. 1997;UNAIDS, Geneva.
19. Glaxo cuts HIV drug cost for developing world. Nature. 392:1998;118.
20. Grinberg L. Expanded access to experimental drugs: activists seek more open programs. AIDS Treatment News, 1997 (number 282): 6-7.
21. Temmerman M., Ndinya-Achola J., Ambani J., Piot P. The right not to know HIV-test results. Lancet. 345:1995;969-970.
22. Rothenberg K.H., Paskey S.J., Reuland M.M., Zimmerman S.I., North R.L. Domestic violence and partner notification. implications for treatment and counseling of women with HIV J Am Med Womens Assoc. 50:1995;87-93.
23. Life-tables: Tanzania, Kenya. 1999;US Bureau of Census International Database, Washington, DC. (available online at www.census.gov/ipc/www/idbacc.html ).
24. Gilson L., Mkanje R., Grosskurth H.et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet. 350:1997;1805-1809.
25. Murray C.L., Lopez A.D. The global burden of disease. 1996;Harvard University Press, Cambridge, MA.
26. Hendriks JC, Van Druten JA, Van Ameijden EJ, Van Griensven GJ, Coutinho RA. Estimation of progression of HIV infection among intravenous drug users using a death-included Markov model. XI International Conference on AIDS. Vancouver, July, 1996 (abstr ThC223).
27. World development report: investing in health. 1993;Oxford University Press, New York.
28. Weinstein M., Graham J., Siegel J., Fineberg H. Cost-effectiveness analysis of AIDS prevention programs: concepts, complications, and illustrations. 1989;National Academy Press, Washington, DC.
29. Rehle T., Saidel T., Hassig S., Bouey P., Gaillard E., Sokal D.C. AVERT: a user friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission. AIDS. 12(suppl 2):1998;S27-S35.
30. Jamison D.T., Mosley W.H. Disease control priorities in developing countries. health policy responses to epidemiological change Am J Public Health. 81:1991;15-22.
31. Sweat M, Balmer D, Sangiwa G. Cost to clients and willingness to pay for HIV counseling and testing in Kenya and Tanzania: results from the voluntary HIV counseling and testing study. XII International Conference on AIDS. Geneva, June-July 1998 (abstr 23135).
32. Coates T, Furlonge C, Mwakagile D, Kamenga C, Schacter J, Gregorich S. Validation of self-reported sexual risk behavior with STD incident rates: results from the voluntary HIV counseling and testing study. XII International Conference on AIDS. Geneva, June-July 1998 (abstr 14107).